Lower blood pressure goals in high-risk cardiovascular patients: are they defensible?

Cardiology Clinics
Keith A Hopkins, George L Bakris

Abstract

This review highlights the paucity of data that support actively decreasing blood pressures (BP) to a level of less than 130/80 mm Hg. Although the data support a lower cardiovascular (CV) event rate with this lower level of pressure in high-risk CV people, early aggressive intervention to prevent levels from going above this mark prevent development of worsening atherosclerosis. Although no trial will ever prove this concept of prevention, common sense and multiple animal experiments support it. Most patients should have their systolic BP reduced to levels well below 140 mm Hg approaching 130 mm Hg, not 140 mm Hg.

References

Oct 8, 1999·Archives of Internal Medicine·G W SomesW B Applegate
Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Oct 16, 2004·Kidney International. Supplement·Lawrence G HunsickerUNKNOWN Collaborative Study Group
Jun 3, 2005·Journal of the American Society of Nephrology : JASN·Tomas BerlUNKNOWN Collaborative Study Group
Sep 15, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Jan A StaessenJi-Guang Wang
Feb 6, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN KDOQI
Jul 12, 2007·The American Journal of Cardiology·UNKNOWN ACCORD Study GroupMark D Sullivan
Jul 12, 2007·The American Journal of Cardiology·William C CushmanUNKNOWN ACCORD Study Group
Jul 27, 2007·Nature Clinical Practice. Nephrology·Robert W SchrierWilliam R Hiatt
Nov 30, 2007·The Journal of Clinical Hypertension·Thomas D Giles
Jul 4, 2008·Journal of Human Hypertension·Je SharmanSs Franklin
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanDavid R Matthews
May 12, 2009·The Medical Clinics of North America·Nitin KhoslaGeorge L Bakris
Sep 29, 2009·Population Health Metrics·Goodarz DanaeiMajid Ezzati
Nov 10, 2009·Diabetes Research and Clinical Practice·J E ShawP Z Zimmet
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi

❮ Previous
Next ❯

Citations

Apr 13, 2011·The American Journal of Cardiology·Steven G Chrysant, George S Chrysant

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.